Back

The impact of residual mitral valve regurgitation on outcome after MitraClip therapy

27 August 2018 (08:43 - 08:56)
Organised by:
Congress Presentation Part of: Advances in structural heart interventions Mitral Valve Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Daniel Reichart

Ludwig Maximilians University, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial
Mr J. Vendrik (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study
Doctor A. Sokoloff (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
6 month follow up results from the european transcatheter tricuspid valve repair multicenter trial
Assistant Professor R. von Bardeleben (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation
Doctor A. Latib (New York, US)
Abstract Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Advances in structural heart interventions

The Event

Event poster

ESC Congress 2018

27 August 2018 08:43 CET
You may be interested in
thumbnail
Congress Session
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Echocardiography in transcatheter interventions for mitral and tricuspid regurgitation: take it to the next level

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources